NCT07646288 Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After Lobectomy
| NCT ID | NCT07646288 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | VATS |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-12-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the acute effects of inspiratory muscle training performed with and without a mobile application providing visual feedback on exercise motivation, patient adherence, dyspnea perception, usability, and patient satisfaction in lung cancer patients undergoing lobectomy via video-assisted thoracic surgery. Participants will perform conventional inspiratory muscle training without visual feedback in the morning on postoperative day 1 after transfer to the ward. After at least two hours of rest, the same exercise protocol will be repeated with a smart adaptor connected to a mobile application to provide visual feedback. Inspiratory muscle training will be performed using a threshold-loading device at 40% of maximal inspiratory pressure, with three sets of ten breaths. Outcomes will be assessed before and/or after each session as appropriate.
Eligibility Criteria
Inclusion Criteria: * Volunteering to participate in the study, * Being clinically stable, * Being a lung cancer patient scheduled for lobectomy, * Being between 18 and 75 years of age, * Being able to cooperate with the tests to be performed. Exclusion Criteria: * Presence of any orthopedic or neurological problem that prevents walking, * History of any surgery involving the thoracic wall, * Having diseases that may affect respiratory parameters, such as severe heart failure or severe chronic obstructive pulmonary disease (COPD).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07646288 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying VATS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07646288 currently recruiting?
Yes, NCT07646288 is actively recruiting participants. Contact the research team at funda.sirakaya@hacettepe.edu.tr for enrollment information.
Where is the NCT07646288 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07646288 clinical trial?
NCT07646288 is sponsored by Hacettepe University. The trial plans to enroll 40 participants.